Chelain R. Goodman, M.D., Ph.D.
Department of Breast Radiation Oncology, Division of Radiation Oncology
About Dr. Chelain R. Goodman
Chelain R. Goodman, M.D., Ph.D. is an Assistant Professor in the Department of Breast Radiation Oncology at The University of Texas MD Anderson Cancer Center and a member of the Morgan Welch Inflammatory Breast Cancer Research Program. She specializes in radiotherapy for early-stage and locally advanced breast cancer, with a focus on patients with inflammatory breast cancer and oligometastatic disease. Dr. Goodman has been recognized as an Andrew Sabin Family Fellow (2026), a Paul Calabresi Clinical Scholar (NCI K12 Clinical Scientist Institutional Career Development Award; 2023-2025), a Breast Cancer Research Foundation Investigator (2022-2023, 2026), and the recipient of the "Under 40" Award for Early Career Breast Oncologists by the European Society for Radiation Oncology (2023). Most recently, she was awarded the Conquer Cancer Foundation Advanced Clinical Research Award for Breast Cancer by the American Society for Clinical Oncology (2026-2029).
Dr. Goodman's research program aims to advance the diagnosis, treatment, and monitoring of breast cancer by integrating innovative imaging and biologic biomarkers with deep learning–based clinical decision-making tools. She is the principal investigator of the PRISM trial, a prospective study evaluating circulating tumor material dynamics to further personalize breast radiotherapy. She also leads the upcoming CLARITy trial, a prospective randomized trial evaluating the benefit of metastasis-directed radiotherapy for patients with oligometastatic breast cancer with no detectable circulating tumor material following upfront subtype-specific systemic therapy. As an Andrew Sabin Family Fellow, her work integrates multimodal imaging biomarkers with deep learning to improve diagnostic precision and early response prediction in inflammatory breast cancer.
In addition to her research and clinical practice, Dr. Goodman is the Department of Breast Radiation Oncology Medical Student Site Director and is dedicated to graduate medical education and to developing consensus-based educational materials to support patients throughout treatment. She is an Associate Editor for the Breast Section of the International Journal of Radiation Oncology * Biology * Physics and serves on committees for numerous specialty-specific societies and cooperative groups, including the American Society for Radiation Oncology (ASTRO) and NRG Oncology.
Present Title & Affiliation
Primary Appointment
Assistant Professor (Tenure Track), Breast Radiation Oncology, Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas
Education & Training
Degree-Granting Education
| 2005 | Swarthmore College, Swarthmore, Pennsylvania, US, Biology, B.A |
| 2015 | Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania, US, Medicine, M.D |
| 2015 | Thomas Jefferson University, Philadelphia, Pennsylvania, US, Molecular Pharmacology and Structural Biology, Ph.D |
Postgraduate Training
| 2016-2020 | Resident, McGaw Medical Center of Northwestern University Feinberg School of Medicine, Chicago, Illinois |
| 2015-2016 | Intern, Lankenau Medical Center, Wynnewood, Pennsylvania |
Licenses & Certifications
| 2022 | Georgia Composite Medical Board |
| 2022 | Tennessee Board of Medical Examiners |
| 2022 | State of Mississippi |
| 2022 | Alabama Board of Medical Examiners |
| 2022 | Arizona Board of Medical Examiners |
| 2022 | State of Oklahoma |
| 2022 | Louisiana State Board of Medical Examiners |
| 2022 | State of Washington |
| 2022 | American Board of Radiology (ABR) |
| 2021 | Florida Board of Medicine |
| 2020 | Drug Enforcement Administration, Controlled Substance Registration Certification |
| 2020 | Texas Medical Board |
| 2019 | Illinois Department of Professional Regulation, Controlled Substance License |
| 2018 | Illinois Department of Professional Regulation |
Experience & Service
Faculty Academic Appointments
Adjunct Assistant Professor, Radiation Oncology, Northwestern University Feinberg School of Medicine, Chicago, IL, 2021 - 2022
Administrative Appointments/Responsibilities
Department of Breast Radiation Oncology Medical Student Site Director, Breast Radiation Oncology, UT MD Anderson Cancer Center, Houston, TX, 2023 - Present
Chief Resident, Department of Radiation Oncology, McGaw Medical Center, Northwestern University Feinberg School of Medicine, Chicago, IL, 2019 - 2020
Other Professional Positions
Clinical Research Coordinator, Mount Sinai School of Medicine, New York, NY, 2005 - 2007
Intramural Institutional Committee Activities
Departmental Representative, Breast Radiation Oncology Site Representative, The University of Texas MD Anderson Cancer Center, 2025 - Present
Workgroup member, MD Anderson Cancer Center Cancer Treatment Algorithms: Breast Cancer - Inflammatory Breast Cancer (IBC), The University of Texas MD Anderson Cancer Center, 2023 - Present
Workgroup Member, MD Anderson Cancer Center Clinical Management Algorithms: Skin Management - Radiation Therapy, The University of Texas MD Anderson Cancer Center, 2023 - Present
Faculty Review Panel, Radiation Oncology Residency Application Review Committee, The University of Texas MD Anderson Cancer Center, 2023 - 2024
Member, Scientific Review Committee, The University of Texas MD Anderson Cancer Center, 2023 - 2024
Committee Member, Breast Radiation Oncology Treatment Guidelines Committee, Department of Breast Radiation Oncology, The University of Texas MD Anderson Cancer Center, 2022 - Present
Elected Representative, Department of Breast Radiation Oncology, Faculty Senate, The University of Texas MD Anderson Cancer Center, 2022 - 2025
Member, Grand Rounds Planning Committee, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 2021 - Present
Extramural Institutional Committee Activities
Chair, Breast Section, ACR Radiation Oncology In-Training (TXIT) Examination, American College of Radiology, 2026 - Present
Departmental Representative, Radiation Oncology, House Staff Association, Northwestern University Feinberg School of Medicine, 2016 - 2018
Vice President, Recruitment (2011-2012); Member (2007-2015), Jefferson Physician Scientist Association (JPSA), Thomas Jefferson University, 2007 - 2015
Editorial Activities
Associate Editor, Breast Section, International Journal of Radiation Oncology, Biology, Physics, 2025 - Present
Honors & Awards
| 2026 - Present | Andrew Sabin Family Foundation Award, The University of Texas MD Anderson Cancer Center |
| 2026 | Golden Glove Quality Safety Award, The University of Texas MD Anderson Cancer Center |
| 2024 | ASTRO Abstract Recognition Award: Biology, American Society for Radiation Oncology |
| 2023 | “Under 40” Award for Early Career Breast Oncologists, European Society for Radiation Oncology (ESTRO) |
| 2022 - 2024 | Paul Calabresi Scholar, The University of Texas MD Anderson Cancer Center |
| 2021 | BCRF Investigator, Breast Cancer Research Foundation (BCRF) |
| 2020 | Susan Perlman Award, Finalist, McGaw Medical Center of Northwestern University Feinberg School of Medicine |
| 2019 | Roentgen Resident Research Award, Radiological Society of North America (RSNA) |
| 2018 | Lasky Foundation Breast Cancer Resident Research Award, Chicago Radiological Society (CRS) |
| 2018 | Publication Award, Honorable Mention, Radiation Oncology Institute (ROI) |
| 2017 | Conquer Cancer Foundation Merit Award, American Society of Clinical Oncology (ASCO) |
| 2017 | Lynn Sage Symposium Scholar Award, 19th Annual Lynn Sage Breast Cancer Symposium |
| 2017 | Best of ASTRO Oral Presentation, American Society for Radiation Oncology (ASTRO) |
| 2013 | Best Poster Presentation Award, MD/PhD Category, Sigma Xi Student Research Day, Jefferson College of Biomedical Sciences, Thomas Jefferson University |
| 2012 | Alumni Association Graduate Student Travel Fellowship Award, Jefferson College of Biomedical Sciences, Thomas Jefferson University |
| 2011 | Rieders Renaissance Foundation Graduate Student Recognition Award, Jefferson College of Biomedical Sciences, Thomas Jefferson University |
| 2009 | Hobart Amory Hare Honor Society Award, Sidney Kimmel Medical College, Thomas Jefferson University |
| 2007 - 2008 | Benjamin & Mary Siddons Measey MD/PhD Fellowship, Sidney Kimmel Medical College, Thomas Jefferson University |
| 2007 | Dubbs MD/PhD Fellowship, Sidney Kimmel Medical College, Thomas Jefferson University |
Professional Memberships
Selected Presentations & Talks
Local Presentations
- 2026. Breast Radiotherapy Treatment Planning: VMAT, Contouring, Tangents, & More. Invited. Division of Radiation Oncology Planning Clinic. Houston, Texas, US.
- 2025. Radiation Oncology: An Introduction to Breast Radiotherapy. Invited. Radiation Oncology Virtual Lecture Series for Medical Students. Houston, Texas, US.
- 2025. From Blood to Bedside: Using Circulating Tumor Material to Personalize Breast Cancer Radiotherapy. Invited. Updates in Advanced Breast Cancer: Local Management and Other New Perspectives. Houston, Texas, US.
- 2025. Advances in the Prevention of Lymphedema in Locally Advanced Breast Cancer. Invited. Breast Cancer Clinical and Translational Research (BCCTR) Conference. Houston, Texas, US.
- 2025. Breast Cancer & Pneumonitis: Is Radiation or Immunotherapy to Blame?. Invited. Division of Radiation Oncology Faculty Quality Assurance Meeting. Houston, Texas, US.
- 2025. Circulating Tumor DNA-Guided Local and Ablative Radiotherapy for Oligometastatic Breast Cancer (CLARITY Trial). Invited. MDACC Breast Minimal Residual Disease Working Group Meeting. Houston, Texas, US.
- 2024. Breast Radiotherapy Treatment Planning: VMAT, Contouring, Tangents, & More. Invited. Division of Radiation Oncology Planning Clinic. Houston, Texas, US.
- 2023. Circulating Tumor Material as a Surrogate and Potential Predictive Biomarker for Breast Radiotherapy. Invited. Minimal Residual Disease Committee Meeting. Houston, Texas, US.
- 2023. Meet the Professor: Dr. Goodman's Path to Radiation Oncology. Invited. ”Meet The Professor” Medical Student Lunchtime Seminar. Houston, Texas, US.
- 2022. Longitudinal Assessment of Circulating Tumor Material as a Surrogate Biomarker for Radiotherapy Treatment Response in Breast Cancer. Invited. NIH/NCI K12 Calabresi Scholar Program Annual Conference. Houston, Texas, US.
- 2021. The Academic Job Search in Radiation Oncology. Invited. Resident Noon Hour Mentorship Session. Houston, TX, US.
- 2020. Breast Radiotherapy Treatment Planning: VMAT, Contouring, Tangents, & More. Invited. Division of Radiation Oncology Planning Clinic. Houston, Texas, US.
- 2020. Non-invasive biomarkers of residual disease in breast cancer: implications for radiotherapeutic management. Invited. Department of Radiation Oncology Grand Rounds. Chicago, Illinois, US.
- 2019. Circulating tumor status as a biomarker to predict the benefit of radiotherapy in early-stage breast cancer. Invited. Department of Radiation Oncology Research Retreat. Chicago, Illinois, US.
- 2018. Radiotherapeutic management of early-stage breast cancer: the potential of circulating tumor cell status. Invited. Radiotherapeutic management of early-stage breast cancer: the potential of circulating tumor cell status. Chicago, IL, US.
- 2017. Oncotype score and benefit of post-mastectomy radiation therapy. Invited. Oncotype score and benefit of post-mastectomy radiation therapy. Chicago, IL, US.
- 2017. Circulating tumor cell status and benefit of radiotherapy in stage I breast cancer. Invited. Circulating tumor cell status and benefit of radiotherapy in stage I breast cancer. Chicago, IL, US.
- 2013. 3-ketosteroid receptor activation induces the emergence of a tumor-initiating phenotype in luminal breast cancer. Conference. AOA Research Symposium. Philadelphia, PA, US.
Regional Presentations
- 2025. Challenging Cases in Breast Radiation Oncology. Visiting. Memorial Sloan Kettering Cancer Center Resident Didactic Series. New York, New York, US.
- 2025. Liquid Tumor Evolution During Breast Radiotherapy. Invited. Advanced Breast Cancer Conference. Houston, Texas, US.
- 2020. Non-invasive biomarkers of residual disease in breast cancer: implications for radiotherapeutic management. Invited. Department of Radiation Oncology Grand Rounds. Chicago, Illinois, US.
- 2019. Non-invasive biomarkers of residual disease in breast cancer: implications for radiotherapeutic management. Invited. Department of Radiation Oncology Grand Rounds. Beverly Hills, CA, US.
- 2019. Non-invasive biomarkers of residual disease in breast cancer: implications for radiotherapeutic management. Invited. Department of Radiation Oncology Grand Rounds. Atlanta, Georgia, US.
- 2019. Non-invasive biomarkers of residual disease in breast cancer: implications for radiotherapeutic management. Invited. Department of Radiation Oncology Research Presentation. New York, NY, US.
- 2019. Circulating tumor status as a biomarker to predict the benefit of radiotherapy in early-stage breast cancer. Invited. Division of Radiation Oncology Grand Rounds. Houston, Texas, US.
National Presentations
- 2026. Biomarkers in Breast Radiation Oncology: Current Landscape and Future Directions. Invited. RUSH • MD Anderson Cancer Center Breast Cancer Symposium 2026. Chicago, Illinois, US.
- 2026. Circulating Tumor Material as a Biomarker for Breast Radiotherapy. Invited. NRG Oncology Translational Science Committee. Philadelphia, Pennsylvania, US.
- 2026. Circulating Tumor Material-Guided Local and Ablative RadIoTherapy for Oligometastatic Breast Cancer (CLARITy): A Phase II Randomized Trial. Invited. NRG Oncology 2026 Winter Meeting: Breast Translational Science Working Group, US.
- 2025. Prospective Analysis of Circulating Tumor Cell Clearance and Dynamics with Adjuvant Radiotherapy in Locally Advanced Breast Cancer. Conference. San Antonio Breast Cancer Symposium (SABCS) 2025 Annual Meeting. San Antonio, TX, US.
- 2025. Repeat breast conservation with re-irradiation: What is the data and how do we do it?. Invited. San Antonio Breast Cancer Symposium (SABCS) 2025 Annual Meeting. San Antonio, TX, US.
- 2024. Association of VMAT versus 3D-CRT Radiotherapy Treatment Technique with Acute Toxicity of Regional Nodal Irradiation: A Secondary Analysis of the SAPHIRe Phase III Randomized Clinical Trial. Conference. San Antonio Breast Cancer Symposium (SABCS) 2024 Annual Meeting. San Antonio, Texas, US.
- 2024. Prospective analysis of circulating tumor cell dynamics during preoperative radiotherapy in locally advanced breast cancer. Poster. American Association for Cancer Research (AACR) Special Conference in Cancer Research: Liquid Biopsy: From Discovery to Clinical Implementation. San Diego, CA, US.
- 2024. Circulating Tumor Cell Clearance Kinetics in Patients Undergoing Adjuvant Radiotherapy for Node-Positive Breast Cancer: A Prospective Observational Cohort Study. Conference. American Society for Radiation Oncology (ASTRO) 2024 Annual Meeting. Washington, DC, US.
- 2023. Breast Radiotherapy Fractionation Decisions (Short versus Long Course). Panelist. Radiation Oncology Virtual Education Rotation (ROVER), US.
- 2022. Novel Approaches to Therapeutic De-escalation for Favorable Early Breast Cancer. Invited. American Society for Radiation Oncology (ASTRO) 2022 Annual Meeting. San Antonio, Texas, US.
- 2022. A history of initial board certification in radiation oncology and opportunities for further modernization in the post-COVID era. Invited. Association of Radiation Oncology Program Coordinators (AROPC) 2022 Annual Retreat, US.
- 2021. Radiation Oncology Jobs Panel, Moderator. Panelist. American Society for Radiation Oncology (ASTRO) 2021 Annual Meeting. Chicago, IL, US.
- 2021. Moving Beyond the 2021 Match. Invited. Association of Directors of Radiation Oncology Programs (ADROP) 2021 Retreat, US.
- 2021. What lessons did we learn from the 2021 Radiation Oncology Match?. Panelist. A Virtual Visiting Professor Network Production (VVPN). Houston, TX, US.
- 2020. Circulating tumor cell status as a predictive biomarker to guide radiotherapy decisions in early-stage breast cancer: a cost-effectiveness analysis. Conference. American Society for Radiation Oncology (ASTRO) 2020 Annual Meeting. Chicago, IL, US.
- 2020. Clinical and educational resources at United States academic radiation oncology residency programs. Invited. American Society for Radiation Oncology (ASTRO) 2020 Annual Meeting. Miami, FL, US.
- 2019. ARRO Executive Committee Chair Address to ASTRO Board of Directors. Invited. American Society for Radiation Oncology (ASTRO) 2019 Annual Meeting, Board of Directors Meeting. Chicago, IL, US.
- 2019. Association of Residents in Radiation Oncology (ARRO), 2018-2019 Update. Presentation by ARRO Executive Committee to the ASTRO Board of Directors and Staff. Conference. American Society for Radiation Oncology (ASTRO) 2019 Advocacy Day. Washington, DC, US.
- 2019. The future of fellowship training in radiation oncology. Conference. Association of Directors of Radiation Oncology Programs (ADROP) 2019 Retreat. Arlington, VA, US.
- 2018. Optimal adjuvant management for FIGO stage III endometrial cancer: Is timing everything?. Conference. American Society for Radiation Oncology (ASTRO) 2018 Annual Meeting. San Antonio, TX, US.
- 2018. Radiotherapeutic management of early-stage breast cancer: the potential of circulating tumor cell status. Invited. CELLSEARCH®+DEPArray™ User Meeting. Philadelphia, PA, US.
- 2017. Oncotype score and benefit of post-mastectomy radiotherapy in T1-2 N1 breast cancer. Conference. American Society for Radiation Oncology (ASTRO) 2017 Annual Meeting. San Diego, CA, US.
International Presentations
- 2025. Dynamics of Circulating Tumor Cell Response with Adjuvant or Pre-Operative Radiotherapy in Locally Advanced Breast Cancer: A Prospective Cohort Study. Conference. European Society for Radiation Oncology (ESTRO) Annual Meeting, 2025. Vienna, AT.
- 2021. Trastuzumab Deruxtecan (T-DXd) plus Concurrent Preoperative Radiotherapy for Patients with Her2-Expressing Breast Cancer with Residual Disease after Neoadjuvant Chemotherapy. OnlineOnly. Recommendations on integration of radiation therapy with targeted treatments for breast cancer consensus meeting. Florence, IT.
- 2021. Early Breast Cancer. Invited. Zambia Virtual Lecture Series for Clinical Oncology, ECHO Project. Houston, US.
Grant & Contract Support
| Date: | 2027 - Present |
| Title: | Integrating Multiparametric Imaging and CirculAting Biomarkers with Probabilistic Deep Learning to Improve Diagnosis and GuidE Therapy for Inflammatory Breast Cancer (IMAGE) |
| Funding Source: | NIH/NCI |
| Role: | PI |
| ID: | 1K08CA319844-01 |
| Date: | 2026 - Present |
| Title: | Multimodal Probabilistic Deep Learning of Quantitative Biomarkers for Diagnostic Precision and Early Response Prediction in Inflammatory Breast Cancer |
| Funding Source: | The University of Texas MD Anderson Cancer Center |
| Role: | PI |
| ID: | 2026-00066365-Y1 |
| Date: | 2026 - Present |
| Title: | Circulating Tumor Material-Guided Local and Ablative Radiotherapy for Oligometastatic Breast Cancer (CLARITy Trial) |
| Funding Source: | American Society of Clinical Oncology (ASCO) |
| Role: | PI |
| ID: | 2026ACRA-2497266579 |
| Date: | 2025 - Present |
| Title: | PRospective assessment of circulating tumor material dynamics for IndividualiSed Monitoring with breast cancer radiotherapy (PRISM) |
| Funding Source: | Myriad Genetics |
| Role: | PI |
| ID: | 00065711-AM1 |
| Date: | 2025 - Present |
| Title: | Development of a Probabilistic Deep Learning Model for Regional Lymph Node Assessment in Invasive Breast Cancer Using Multi-Modal Imaging |
| Funding Source: | NLM |
| Role: | Mentor |
| ID: | T15LM007093-33 |
| Date: | 2023 - 2025 |
| Title: | Molecular and genomic characterization of circulating tumor material serially collected throughout breast radiotherapy |
| Funding Source: | UT MD Anderson Cancer Center |
| Role: | PI |
| ID: | 2023-00062178 |
| Date: | 2022 - 2027 |
| Title: | Evaluating the clinical utility of circulating tumorderived material dynamics during breast radiotherapy |
| Funding Source: | University of Texas MD Anderson Cancer Center |
| Role: | PI |
| Date: | 2022 - 2025 |
| Title: | Longitudinal Assessment of Circulating Tumor Material as a Surrogate Biomarker for Radiotherapy Treatment Response in Breast Cancer: A Prospective Cohort Study |
| Funding Source: | NIH/NCI |
| Role: | PI |
| ID: | 2K12CA088084-21 |
| Date: | 2021 - 2024 |
| Title: | Circulating tumor-derived material as a surrogate biomarker for radiotherapeutic efficacy in breast cancer |
| Funding Source: | American Society for Therapeutic Radiology and Oncology (ASTRO) |
| Role: | PI |
| ID: | CDA-2021-01-BCRF |
| Date: | 2019 - 2020 |
| Title: | Radiotherapy for early-stage breast cancer based on circulating tumor cell status: feasibility of a prospective biomarker-directed cohort study |
| Funding Source: | The Friends of Prentice Grant Initiative |
| Role: | Mentored (Resident) Principal Investigator |
| Date: | 2019 - 2020 |
| Title: | Feasibility of a prospective biomarker-directed cohort study of circulating tumor cell status in early breast cancer |
| Funding Source: | Robert H. Lurie Clinical Cancer Center, Lurie Cancer Center Research Award |
| Role: | Mentored (Resident) Co-Investigator |
| Date: | 2018 - 2021 |
| Title: | Targeted therapy for the treatment of cervical cancer: utilizing nanoparticles to radiosensitize cancer cells |
| Funding Source: | The Brinson Foundation Medical Research Junior Investigator Award |
| Role: | Mentored (Resident) Principal Investigator |
| ID: | 60049091 |
Selected Publications
Peer-Reviewed Articles
- Shaitelman SF, Krishnamurthy S, Lin H, Rauch GM, Shen Y, Valero V, Johnson HM, Muruganandham M, Smith BD, Hoffman KE, Lee BM, Shinn E, Symmans FW, Woodward WA, Mitchell MP, Goodman CR, Buzdar A, Singh P, Tamirisa N, Kuerer H, Division of Radiation Oncology Biomarker Strategic Initiative Laboratory Group, Exceptional Responders Study Group. Definitive, stereotactic ablative radiotherapy and endocrine therapy without surgery for select low-risk breast cancers: A prospective, phase II trial. Radiother Oncol 111573, 2026. e-Pub 2026. PMID: 42142534.
- Popovic J, Hahut A, Torres G, Vincent A, Soto N, Wray B, Bartom E, Paunesku T, Goodman CR, Woloschak G. Sequential CRISPR/Cas9 Editing of the Epidermal Growth Factor Receptor Ligand-Binding Domain Followed by Whole-Genome Profiling and Phenotype Evaluation of Resultant Mutant Cervical Cancer Cells. Sci Rep 16(1):6797, 2026. e-Pub 2026. PMID: 41620519.
- Jacomina LE, Swanson DM, Mitchell MP, Woodward WA, Smith BD, Hoffman KE, Goodman CR, Garber HR, Sun SX, Yap TA, Meric-Bernstam F, Arzu IY, Bloom ES, Schlembach PJ, Strom EA, Stauder MC, Shaitelman SF. Outcomes After Palliative Radiation Therapy in Patients With Symptomatic Locoregionally Advanced Breast Cancer. Int J Radiat Oncol Biol Phys 122(2):278-291, 2025. e-Pub 2025. PMID: 39549757.
- Basree MM, MacDuffie E, LeCompte M, White ZB 2nd, Ogunmuyiwa J, Sharifzadeh Y, Corrigan K, Neibart SS, Goodman CR, Sim AJ, Hutten RJ, Currey A, Pinnix CC, Kamrava M, Nelson B. Trends in Program Satisfaction and Perceived Confidence Levels Among United States Radiation Oncology Residents: A 5-Year Aggregate Analysis of the 2020-2024 Association of Residents in Radiation Oncology Graduating Resident Survey. Int J Radiat Oncol Biol Phys, 2025. e-Pub 2025. PMID: 40164356.
- LeCompte MC, Sim AJ, Goodman CR, Bajaj A, Kumar A, MacDuffie E, Corrigan KK, Franco I, Nelson BA, Dooley S, Anderson JD, Jeans EB, Tye K, Gaines DK, Vidal G, Agarwal A, Albert AA, Campbell SR. Results of the 2020-2023 Association of Residents in Radiation Oncology Graduating Resident Survey: Job Search Experience and Satisfaction. Int J Radiat Oncol Biol Phys, 2025. e-Pub 2025. PMID: 40147706.
- Chen X, Zhao Y, Baroudi H, El Basha MD, Daniel A, Gay SS, Yu C, Wang H, Phan J, Choi SL, Goodman CR, Zhang X, Niedzielski JS, Shete SS, Court LE, Liao Z, Lofman F, Balter PA, Yang J. Comparison of Vendor-Pretrained and Custom-Trained Deep Learning Segmentation Models for Head-and-Neck, Breast, and Prostate Cancers. Diagnostics (Basel) 14(24), 2024. e-Pub 2024. PMID: 39767212.
- Corrigan KL, Bankston ME, Holliday EB, Shaitelman SF, Lee A, Goodman CR, Fuller CD, Chino FL, Thomas CR Jr, Jagsi R, Ludmir EB. Disease Site Specialization in the Academic Radiation Oncology Workforce: Evidence of Gender Differences. Int J Radiat Oncol Biol Phys 120(4):936-939, 2024. e-Pub 2024. PMID: 38897359.
- Weng JK, Virk R, Kaiser K, Hoffman KE, Goodman CR, Mitchell M, Shaitelman S, Schlembach P, Reed V, Wu CF, Xiao L, Smith GL, Smith BD. Automated, Real-Time Integration of Biometric Data From Wearable Devices With Electronic Medical Records: A Feasibility Study. JCO Clin Cancer Inform 8:e2400040, 2024. e-Pub 2024. PMID: 39348612.
- Gandhi A, Xu T, DeSnyder SM, Smith GL, Lin R, Barcenas CH, Stauder MC, Hoffman KE, Strom EA, Ferguson S, Smith BD, Woodward WA, Perkins GH, Mitchell MP, Garner D, Goodman CR, Aldrich M, Travis M, Lilly S, Bedrosian I, Shaitelman SF. Prospective, early longitudinal assessment of lymphedema-related quality of life among patients with locally advanced breast cancer: The foundation for building a patient-centered screening program. Breast 68:205-215, 2023. e-Pub 2023. PMID: 36863241.
- Bralet MC, Mitelman SA, Goodman CR, Lincoln S, Hazlett EA, Buchsbaum MS. Fluorodeoxyglucose positron emission tomography scans in patients with alcohol use disorder. Alcohol Clin Exp Res 46(6):994-1010, 2022. e-Pub 2022. PMID: 35451074.
- Dover LL, Hentz C, Kahn JM, Lee A, Masters A, Doke K, Goodman CR. Implications of Medical Board Certification Practices on Family Planning and Professional Trajectory for Early Career Female Radiation Oncologists. Pract Radiat Oncol 12(2):95-102, 2022. e-Pub 2022. PMID: 35000892.
- Corrigan KL, Lei X, Ahmad N, Arzu I, Bloom E, Chun SG, Goodman C, Hoffman KE, Joyner M, Mayo L, Mitchell M, Nead KT, Perkins GH, Reed V, Reddy JP, Schlembach P, Shaitelman SF, Stauder MC, Strom EA, Tereffe W, Wiederhold L, Woodward WA, Smith BD. Adoption of Ultrahypofractionated Radiation Therapy in Patients With Breast Cancer. Adv Radiat Oncol 7(2):100877, 2022. e-Pub 2022. PMID: 35387420.
- Rogacki K, Gutiontov S, Goodman CR, Jeans EB, Hasan Y, Golden DW. Analysis of the radiation oncology in-training examination content using a clinical care path conceptual framework. Applied Radiation Oncology 10(3):41-51, 2021. e-Pub 2021.
- Goodman CR, Sim AJ, Jeans EB, Anderson JD, Dooley S, Agarwal A, Tye K, Albert A, Gillespie EF, Tendulkar RD, Fuller CD, Kavanagh BD, Campbell SR. No Longer a Match: Trends in Radiation Oncology National Resident Matching Program (NRMP) Data from 2010-2020 and Comparison Across Specialties. Int J Radiat Oncol Biol Phys 110(2):278-287, 2021. e-Pub 2021. PMID: 33716120.
- Marsiglio JA, Rosenberg DM, Rooney MK, Goodman CR, Gillespie EF, Hirsch AE, Holliday EB, Kimple RJ, Thomas CR Jr, Golden DW. Mentorship Initiatives in Radiation Oncology: A Scoping Review of the Literature. Int J Radiat Oncol Biol Phys 110(2):292-302, 2021. e-Pub 2021. PMID: 33412265.
- Bates JE, Parekh A, Goodman CR, Chowdhary M, Culbert MM, Royce TJ, Amdur RJ. The Geography of Employment Outcomes for Radiation Oncology Graduates in 2019. Int J Radiat Oncol Biol Phys 109(4):1119-1123, 2021. e-Pub 2021. PMID: 33239210.
- Campbell SR, Jeans EB, Albert A, Agarwal A, Tye K, Goodman CR. Radiation Oncology Initial Certification Qualification Examinations: The Resident Experience in 2019. Pract Radiat Oncol 11(1):5-12, 2021. e-Pub 2021. PMID: 32428765.
- Rice SR, Saboury B, Houshmand S, Salavati A, Kalbasi A, Goodman CR, Werner TJ, Vujaskovic Z, Simone CB 2nd, Alavi A. Quantification of global lung inflammation using volumetric 18F-FDG PET/CT parameters in locally advanced non-small-cell lung cancer patients treated with concurrent chemoradiotherapy: a comparison of photon and proton radiation therapy. Nucl Med Commun 40(6):618-625, 2019. e-Pub 2019. PMID: 31095527.
- Goodman CR, Hatoum S, Seagle BL, Donnelly ED, Barber EL, Shahabi S, Matei DE, Strauss JB. Association of chemotherapy and radiotherapy sequence with overall survival in locoregionally advanced endometrial cancer. Gynecol Oncol 153(1):41-48, 2019. e-Pub 2019. PMID: 30660345.
- Albert AA, Knoll MA, Doke K, Masters A, Lee A, Dover L, Hentz C, Puckett L, Goodman CR, Osborn VW, Barry P, Jagsi R. #WomenWhoCurie: Leveraging Social Media to Promote Women in Radiation Oncology. Adv Radiat Oncol 4(2):218-225, 2019. e-Pub 2019. PMID: 31011664.
- Goodman CR, Strauss JB. Circulating Tumor Cells and Radiotherapy Benefit in Early Breast Cancer-Reply. JAMA Oncol 5(1):112, 2019. e-Pub 2019. PMID: 30476949.
- Goodman CR, Seagle BL, Kocherginsky M, Donnelly ED, Shahabi S, Strauss JB. 21-Gene Recurrence Score Assay Predicts Benefit of Post-Mastectomy Radiotherapy in T1-2 N1 Breast Cancer. Clin Cancer Res 24(16):3878-3887, 2018. e-Pub 2018. PMID: 29685878.
- Goodman CR, Seagle BL, Friedl TWP, Rack B, Lato K, Fink V, Cristofanilli M, Donnelly ED, Janni W, Shahabi S, Strauss JB. Association of Circulating Tumor Cell Status With Benefit of Radiotherapy and Survival in Early-Stage Breast Cancer. JAMA Oncol 4(8):e180163, 2018. e-Pub 2018. PMID: 29800954.
- Sachdev S, Goodman CR, Neuschler E, Kalakota K, Cutright D, Donnelly ED, Hayes JP, Prescott AE, Mirabelli G, Strauss JB. Radiotherapy of MRI-detected involved internal mammary lymph nodes in breast cancer. Radiat Oncol 12(1):199, 2017. e-Pub 2017. PMID: 29258542.
- Seagle BL, Shilpi A, Buchanan S, Goodman C, Shahabi S. Low-grade and high-grade endometrial stromal sarcoma: A National Cancer Database study. Gynecol Oncol 146(2):254-262, 2017. e-Pub 2017. PMID: 28596015.
- Goodman CR, DeNittis A. Photon irradiation using a water bath technique for treatment of confluent carcinoma in situ of the hand, digits, and nail bed: a case report. J Med Case Rep 11(1):86, 2017. e-Pub 2017. PMID: 28356127.
- Goodman CR, Sato T, Peck AR, Girondo MA, Yang N, Liu C, Yanac AF, Kovatich AJ, Hooke JA, Shriver CD, Mitchell EP, Hyslop T, Rui H. Steroid induction of therapy-resistant cytokeratin-5-positive cells in estrogen receptor-positive breast cancer through a BCL6-dependent mechanism. Oncogene 35(11):1373-85, 2016. e-Pub 2016. PMID: 26096934.
- Sato T, Tran TH, Peck AR, Girondo MA, Liu C, Goodman CR, Neilson LM, Freydin B, Chervoneva I, Hyslop T, Kovatich AJ, Hooke JA, Shriver CD, Fuchs SY, Rui H. Prolactin suppresses a progestin-induced CK5-positive cell population in luminal breast cancer through inhibition of progestin-driven BCL6 expression. Oncogene 33(17):2215-24, 2014. e-Pub 2014. PMID: 23708665.
- Most P, Lerchenmuller C, Rengo G, Mahlmann A, Ritterhoff J, Rohde D, Goodman C, Busch CJ, Laube F, Heissenberg J, Pleger ST, Weiss N, Katus HA, Koch WJ, Peppel K. S100A1 deficiency impairs postischemic angiogenesis via compromised proangiogenic endothelial cell function and nitric oxide synthase regulation. Circ Res 112(1):66-78, 2013. e-Pub 2013. PMID: 23048072.
- Schneiderman JS, Hazlett EA, Chu KW, Zhang J, Goodman CR, Newmark RE, Torosjan Y, Canfield EL, Entis J, Mitropoulou V, Tang CY, Friedman J, Buchsbaum MS. Brodmann area analysis of white matter anisotropy and age in schizophrenia. Schizophr Res 130(1-3):57-67, 2011. e-Pub 2011. PMID: 21600737.
- Buchsbaum MS, Haznedar M, Newmark RE, Chu KW, Dusi N, Entis JJ, Goldstein KE, Goodman CR, Gupta A, Hazlett E, Iannuzzi J, Torosjan Y, Zhang J, Wolkin A. FDG-PET and MRI imaging of the effects of sertindole and haloperidol in the prefrontal lobe in schizophrenia. Schizophr Res 114(1-3):161-71, 2009. e-Pub 2009. PMID: 19695836.
- Hollander E, Buchsbaum MS, Haznedar MM, Berenguer J, Berlin HA, Chaplin W, Goodman CR, LiCalzi EM, Newmark R, Pallanti S. FDG-PET study in pathological gamblers. 1. Lithium increases orbitofrontal, dorsolateral and cingulate metabolism. Neuropsychobiology 58(1):37-47, 2008. e-Pub 2008. PMID: 18781089.
- Garakani A, Buchsbaum MS, Newmark RE, Goodman C, Aaronson CJ, Martinez JM, Torosjan Y, Chu KW, Gorman JM. The effect of doxapram on brain imaging in patients with panic disorder. Eur Neuropsychopharmacol 17(10):672-86, 2007. e-Pub 2007. PMID: 17560768.
Invited Articles
- Goodman CR, Sun SX, Lucci A, Stauder MC, Woodward WA. Contemporary Locoregional Therapy for Inflammatory Breast Cancer: Don’t De-Escalate Off Protocol. Current Breast Cancer Reports 17(37), 2025. e-Pub 2025.
Review Articles
- Hurwitz MD, Chundury A, Goodman CR, Jones J, Lo SS, Saeed H, Small W Jr, Schechter NR. ACR-ARS Practice Parameter on Informed Consent Radiation Oncology. Am J Clin Oncol 46(6):231-235, 2023. e-Pub 2023. PMID: 36882916.
- Goodman CR, Speers CW. The Role of Circulating Tumor Cells in Breast Cancer and Implications for Radiation Treatment Decisions. Int J Radiat Oncol Biol Phys 109(1):44-59, 2021. e-Pub 2021. PMID: 32882354.
- Volkers M, Rohde D, Goodman C, Most P. S100A1: a regulator of striated muscle sarcoplasmic reticulum Ca2+ handling, sarcomeric, and mitochondrial function. J Biomed Biotechnol 2010:178614, 2010. e-Pub 2010. PMID: 20368797.
Professional Educational Materials
- MD Anderson Cancer Center Radiation Oncologists. Skin Management – Radiation Therapy. University of Texas MD Anderson Cancer Center, 2024.
- MD Anderson Cancer Center Breast Oncologists. Breast Cancer – Inflammatory (IBC). The University of Texas MD Anderson Cancer Center, 2023.
- Goodman CR. Breast Radiation Oncology – Helpful Tidbits.
- Goodman CR, Stauder MC. Department of Breast Radiation Oncology Resident Orientation.
Other Articles
- Goodman C, Sato T, Rui H 3-ketosteroid receptor activation induces the emergence of a drug-resistant basal/progenitor phenotype in luminal breast cancers through Bcl6. AOA Research Symposium, 2013.
Editorials
- Das IJ, Shumway J, Goodman CR, Chowdhary M, Sim AJ, Bates JE, Mohindra P, Su Z, Choi JI, Salama J, Weisman M, Shah C. Adaptive Radiation Therapy: Workforce Implications. Int J Radiat Oncol Biol Phys 122(4):881-883, 2025. PMID: 40571369.
- Goodman CR, Barcenas CH. Liquid biopsy in advanced and metastatic breast cancer: translating prognostic value to clinical implementation. Transl Cancer Res 14(4):2178-2182, 2025. PMID: 40386269.
- Goodman CR, Strauss JB. Balancing Act: Optimizing Dose and Volume. Int J Radiat Oncol Biol Phys 120(2):317-318, 2024. PMID: 39244351.
- Goodman CR, Strauss JB. One Way or Another: An Oligorecurrence After an Oligometastasis of an Estrogen Receptor-Positive Breast Cancer. Int J Radiat Oncol Biol Phys 114(4):571-572, 2022. PMID: 36244388.
- Dooley S, Sim AJ, Campbell SR, Jeans EB, Anderson JD, Tye K, Goodman CR. Opportunities to Improve Radiation Oncology Medical Education in the Post-Pandemic Era. Int J Radiat Oncol Biol Phys 108(2):455-457, 2020. PMID: 32890531.
- Goodman CR, Campbell SR, Jeans EB, Agarwal A, Tye K, Kahn JM. Modernization of Board Certification in Radiation Oncology: Opportunities Following COVID-19. Int J Radiat Oncol Biol Phys 108(2):458-461, 2020. PMID: 32890532.
- Kahn J, Goodman CR, Albert A, Agarwal A, Jeans E, Tye K, Campbell SR, Marcrom S, Colbert LE. Top Concerns of Radiation Oncology Trainees in 2019: Job Market, Board Examinations, and Residency Expansion. Int J Radiat Oncol Biol Phys 106(1):19-25, 2020. PMID: 31648872.
Abstracts
- Goodman CR, Shaitelman SF, Ramezani S, Hoffman KE, Mitchell MP, Comeaux N, Zia A, Barcenas C, Lim B, Smith B, Lucci A, Woodward WA. Abstract PD5-07: Prospective Analysis of Circulating Tumor Cell Clearance and Dynamics with Adjuvant Radiotherapy in Locally Advanced Breast Cancer. Clin Cancer Res 32(4_Supplement):PD5-07, 2026. e-Pub 2026.
- Ramezani S, Le-Petross H, Naser M, Young RV, Morris TK, Kai M, Stauder M, Lim B, Lucci A, MDACC-IBC, Fuller CD, Woodward WA, Goodman CR. Abstract PS3-04-17: Deep Learning Classification of Inflammatory Breast Cancer Using Multiparametric MRI: A Multi-Sequence Analysis. Clin Cancer Res 32(4_Supplement)(PS3-04-17), 2026. e-Pub 2026.
- Hercule WS, Barbosa M, Goodman CR, Gillespie EF, Hirsch AE, Holliday E, Kimple RJ, Rooney MK, Thomas Jr, CR, Golden DW. Abstract 2601: A Five-Year Update of a Scoping Review of Mentorship Initiatives in Radiation Oncology. IJROBP 123(1(1)):e267, 2025. e-Pub 2025.
- Goodman CR, Shaitelman SF, Hoffman KE, Mitchell MP, Strauss JB, Zia A, Comeaux NI, Virk R, Lin R, Nead KT, Stauder MC, Strom EA, Perkins G., Bloom E., Reed V, Joyner MM, Schlembach P, Lim B, Barcenas CH, Smith BD, Lucci A, Woodward WA. Abstract 4619: Dynamics of Circulating Tumor Cell Response with Adjuvant or Pre-Operative Radiotherapy in Locally Advanced Breast Cancer: A Prospective Cohort Study. Radiotherapy & Oncology 206:S630-S640, 2025. e-Pub 2025.
- Goodman CR, Mitchell MP, Ramezani S, Shaitelman SF, Zacharia RF, Arzu IY, Bloom E, Fuller CD, Joyner MM, Mayo LL, Perkins GH, Reddy J, Singh P, Stauder MC, Strom EA, Reed V, Schlembach P, Woodward WA, Smith BD, Hoffman KE. Abstract PS6-02: Association of VMAT versus 3D-CRT Radiotherapy Treatment Technique with Acute Toxicity of Regional Nodal Irradiation: A Secondary Analysis of the SAPHIRe Phase III Randomized Clinical Trial. Clin Cancer Res 31(12_Supplement):PS6-02, 2025. e-Pub 2025.
- Goodman CR, Shaitelman SF, Ramezani S, Strauss JB, Zia A, Comeaux NI, Virk R, Lin R, Nead K, Mitchell MP, Hoffman KE, Strom EA, Stauder MC, Perkins G, Reed V, Bloom E, Joyner MM, Schlembach P, Lim B, Barcenas CH, Lucci A, Woodward WA. Abstract B04: Prospective analysis of circulating tumor cell dynamics during preoperative radiotherapy in locally advanced breast cancer. Clin Cancer Res 30(21_Supplement):B014, 2024. e-Pub 2024.
- Goodman CR, Strauss JB, Shaitelman SF, Smith BD, Zia A, Comeaux NI, Nead KT, Mitchell MP, Hoffman KE, Strom EA, Stauder MC, Perkins GH, Reed VK, Bloom E, Joyner MM, Schlembach PJ, Barcenas CH, Lucci A, Woodward WA. Abstract 1107: Circulating Tumor Cell Clearance Kinetics in Patients Undergoing Adjuvant Radiotherapy for Node-Positive Breast Cancer: A Prospective Observational Cohort Study. International Journal of Radiation Oncology Biology Physics 120(2):S199-S200, 2024. e-Pub 2024.
- Seol SW, Pflederer T, Weller L, Goodman CR, Donnelly ED, Hayes JP. Radiotherapy versus endocrine therapy for hormone receptor positive early stage breast cancer accounting for endocrine therapy adherence. Radiotherapy & Oncology 82((4_Supplement)):P1-13-03, 2022. e-Pub 2022.
- Shaitelman SF, Gandhi A, Xu T, DeSnyder S, Smith GL, Lin R, Barcenas C, Stauder MC, Hoffman KE, Strom EA, Ferguson S, Smith BD, Woodward WA, Perkins GH, Mitchell MP, Goodman CR, Aldrich M, Travis M, Lilly S. Prospective, Longitudinal Assessment of Lymphedema-related Quality of Life for Locally Advanced Breast Cancer Patients: A Foundation for Needed Elements in a Lymphedema Screening Program. American Radium Society (ARS) 2022 Annual Meeting, 2022.
- Seol SW, Pflederer T, Weller L, Goodman CR, Donnelly ED, Strauss JB. A comparison of outcomes in early breast cancer after external beam radiotherapy, intraoperative radiotherapy, or observation: A retrospective cohort study across a large health system. International Journal of Radiation Oncology Biology Physics 111(S3):e211-e212, 2021. e-Pub 2021.
- Bajaj A, Petras K, Goodman CR, Donnelly ED, Hayes JP, Strauss JB. Cardiac Substructure Dose in Patients Undergoing Cardiac-Sparing Techniques for Whole Breast Radiotherapy or Partial Breast Irradiation: A Dosimetric Follow-Up to IMPORT LOW. International Journal of Radiation Oncology Biology Physics 111(S3):e204, 2021. e-Pub 2021.
- Seol SW, Pflederer T, Weller L, Goodman C, Donnelly E, Hayes J, Strauss J. Irradiation With or Without Boost in Low Risk Early Breast Cancer: Data from a Large Health System. Radiotherapy & Oncology 161(Supplement 1):S154-S155, 2021. e-Pub 2021.
- Seol SW, Weller L, Pflederer T, Goodman CR, Donnelly ED, Hayes JP. Avoidance of radiotherapy for low risk early breast cancer using LUMINA Trial criteria and accounting for endocrine therapy adherence. Cancer Res 82 (4_Supplement):PD7-04, 2021. e-Pub 2021.
- Seol SW, Pflederer T, Goodman CR, Donnelly ED, Prescott A, Weller L, Strauss JB. Outcomes of breast brachytherapy in Stage I breast cancer – data from a large health system. International Journal of Radiation Oncology Biology Physics 108(S3):e42, 2020. e-Pub 2020.
- Bajaj A, Petras K, Goodman CR, Elmasri A, Donnelly ED, Hayes JP, Phillip R, Wozniak M, Strauss JB. The impact of cardiac sparing techniques on heart and lung dose in the setting of partial breast irradiation: a dosimetric follow-up to the IMPORT Low Trial. International Journal of Radiation Oncology Biology Physics 108(S3):e31, 2020. e-Pub 2020.
- Rogacki K, Goodman CR, Gutiontov S, Jeans E, Hasan Y, Strauss JB, Golden DW. Analysis of Question Content of the American College of Radiology Radiation Oncology In-Training Examination Years 2016-2019. International Journal of Radiation Oncology Biology Physics 108(S3):e439, 2020. e-Pub 2020.
- Goodman CR, Popovic J, Quinn J, Paunesku T, Woloschak G. Nuclear delivery of radiosensitizing EGFR-targeted nanoparticles is abrogated in isogenic cervical cancer cell lines following mutagenesis of the ligand binding domain. International Journal of Radiation Oncology Biology Physics 105(S1):e677, 2019. e-Pub 2019.
- Popovic J, Paunesku T, Ibrahim M, Smith A, Goodman CR, Woloschak G. The effect of radiation on isogenic cervical cancer cell lines derived by CRISPR/Cas9 editing of Epidermal Growth Factor Receptor. Radiation Research Society, 2019.
- Barry P, Hentz C, Albert A, Knoll M, Doke K, Masters A, Lee A, Dover L, Puckett L, Goodman C, Osborn V, Jagsi R. Society of Women in Radiation Oncology (SWRO) Perspective Piece/Inspirational Spotlight. Inaugural Women in Medicine Summit, 2019.
- Hentz C, Albert A, Doke K, Dover L, Henson-Masters A, Lee A, Puckett L, Goodman C, Barry P. Advancing women in Radiation Oncology: The start of SWRO, #WomenWhoCurie Day, and Future Directions. American College of Radiation Oncology (ACRO) Annual Meeting 2019, 2019.
- Goodman CR, Amin NP, Zainib M, Mohindra P, Arshad M, Cutright D, Berman AT, Schonewolf CA, Beydoun H, Dominello MM, Feigenberg SJ, Simone CB, Kruser TJ. Stereotactic body radiotherapy to multiple sites of intrathoracic disease: A multi-institutional analysis. International Journal of Radiation Oncology Biology Physics 102(S3):e683, 2018. e-Pub 2018.
- Seagle BL, Goodman CR, Shahabi S. Sentinel lymph node biopsy versus lymphadenectomy in Type II endometrial cancer: A National Cancer Database analysis. Society of Gynecologic Oncology (SGO) Winter Conference, 2018.
- Goodman CR, Seagle BL, Donnelly ED, Shahabi S, Strauss JB. Oncotype score and benefit of post-mastectomy radiotherapy in T1-2 N1 breast cancer. International Journal of Radiation Oncology Biology Physics 98(2 (1)):S53, 2017. e-Pub 2017.
- Goodman CR, Seagle BL, Donnelly ED, Strauss JB, Shahab S. Circulating tumor cell status and benefit of radiotherapy in Stage I breast cancer. Journal of Clinical Oncology 35(15_supp):11524, 2017. e-Pub 2017.
- Goodman CR, Dalal P, Cutright D, Paudel N, Kim T, Gentile M, Kruser TJ. Clinical Outcomes Following Stereotactic Body Radiotherapy to Multiple Sites of Intrathoracic Disease. International Journal of Radiation Oncology Biology Physics 98(1):250-251, 2017. e-Pub 2017.
- Goodman CR. Alternative quantification of global lung glycolysis using volumetric FDG PET/CT parameters in lung cancer patients treated with radiotherapy. Journal of Nuclear Medicine 56(S3):1288, 2015. e-Pub 2015.
- Goodman CR, Sato T, Peck AR, Girondo M, Liu C, Kovatich A, Hooke J, Shriver C, Mitchell E, Hyslop T, Rui H. Glucocorticoid and aldosterone mimic progestin-induction of a therapy-resistant cytokeratin-5 positive cell population in estrogen receptor-positive breast cancer through a Bcl6-dependent mechanism. Cancer Research 75(9_supplement):P3-05-10, 2014. e-Pub 2014.
- Goodman CR, Sato T, Peck AR, Girondo MA, Liu C, Kovatich AJ, Hooke JA, Shriver CD, Mitchell EP, Hyslop T, Rui H. 3-ketosteroids induce the expansion of a therapy-resistant cytokeratin-5 positive cell population in luminal breast cancer via the transcriptional repressor Bcl6. San Antonio Breast Cancer Symposium, 2014.
- Goodman C, Sato T, Fay E, Rui H. Prolactin represses glucocorticoid-induced expression of transcriptional repressor Bcl6 and the dedifferentiation to a basal/progenitor phenotype in breast cancer. Federation of American Societies for Experimental Biology (FASEB), 2012.
- Buchsbaum MS, Teague EB, Goodman C, Haznedar MM, Raio C, Bernacer-Maria J, Hazlett E. Fronto-striatal-thalamic functional connectivity assessed by FDG-PET during tasks in schizophrenia. Organization for Human Brain Mapping, 2010.
- Teague EA, Hazlett EA, Entis J, Canfield EL, Goodman C, Haznedar MM, Raio C, Bernacer J, Buchsbaum MS. Hypofrontality and the Fronto-Striato-Thalamic Pathway During Attentional Tasks. 9th World Congress of Biological Psychiatry, 2009.
- Nenadic I, Hazlett E, Friedman J, Haznedar M, Chu, KW, Entis J, Goodman CR, Newmark R, Robson A, Zhang J, Canfield E, Buchsbaum M. Anisotropy and tractography in the internal capsule in the schizophrenia spectrum. Schizophrenia Research 1(102):72, 2008. e-Pub 2008.
- Schneiderman JS, Friedman J, Goodman CR, Newmark RE, Torosjan Y, Camfield EL, Entis J, Estefanel K, Mitropoulou V, Tang C, Hajianpour A, Davis KL, Gorman J, Buchsbaum MS. Cortical white matter diffusion tensor anisotropy in schizophrenia. Biological Psychiatry 63(7):277S, 2008. e-Pub 2008.
- Buchsbaum M, Byne W, Chu KW, Goldstein K, Goodman C, Haznedar MM, Hazlett EA, Kemether E, Newmark R, Torosjan Y. Size, FDG-PET activity, and neuroleptic responsivity of the mediodorsal nucleus of the thalamus in schizophrenia. European Neuropsychopharmacology 17(S4):S291-292, 2007. e-Pub 2007.
- Goodman CR, Seagle BL, Donnelly ED, Shahabi S, Strauss JB. Optimal Adjuvant Management for FIGO Stage III Endometrial Cancer: Is Timing Everything?. International Journal of Radiation Oncology*Biology*Physics 102(3):S222-S223, 2006. e-Pub 2006.
- Kemether E, Bark N, Newmark R, Byne W, Chu K, Goldstein K, Goodman C, Gupta A, Haznedar MM, Hazlett E, Torosjan Y, Buchsbaum MS. FDG-PET imaging of the effects of sertindole in the striatum, thalamus, and prefrontal cortex in schizophrenia. European Neuropsychopharmacology 16:S414, 2006. e-Pub 2006.
- Strain G, Gagner M, Pomp A, Inabnet W, Newmark R, Goodman C, Buchsbaum M. Differences in brain metabolism of lean and morbidly obese persons and the effect of weight loss surgery in response to food cues as assessed with 18-fluoro-2-deoxyglucose (FDG) and positron emission tomography (PET). Obesity Reviews 7(Suppl. 2):53, 2006. e-Pub 2006.
- Kemether E, Bark N, Buchsbaum MS, Byne W, Chu K, Goldstein K, Goodman C, Gupta A, Haznedar MM, Hazlett E, Newmark R, Torosjan Y, Zhang J, Wolkin A. Thalamocortical effects of sertindole and haloperidol assessed by FDG-PET in schizophrenia. International Journal of Neuropsychopharmacology 9:S282, 2006. e-Pub 2006.
- Goodman C, Irvine EE. Upregulation of c-Fos in learning- and memory-implicated brain regions following training and retrieval in mice. Sigma Xi Conference, Swarthmore College, 2004.
- Thomas R, Ramezani S, Stauder MC, Le-Petross H, Lim B, Lucci A, Woodward WA, Goodman CR. Outcomes of Trimodality Therapy in Her2-Positive De Novo Metastatic Inflammatory Breast Cancer. American College of Radiation Oncology (ACRO).
Book Chapters
- Goodman CR, Smith BD. Radiotherapy for Locally Advanced Breast Cancer: Historical Review to Current Approaches. In: The Breast: Comprehensive Management of Benign and Malignant Diseases. 6. Elsevier, Inc, 2023.
- Goodman CR, Donnelly ED. Ovary and Fallopian Tube. In: Radiation Oncology Management Decisions. 4. Lippincott Williams & Wilkins, 2019.
- Goodman CR, Donnelly ED. Uterine Cervix. In: Radiation Oncology Management Decisions. 4. Lippincott Williams & Wilkins, 2019.
Letters to the Editor
- Dooley S, Sim AJ, Campbell SR, Jeans EB, Anderson JD, Tye K, Goodman CR. In Reply to Taunk et al. Int J Radiat Oncol Biol Phys 109: 835-836, 2021.
- Agarwal A, Royce TJ, Goodman CR, Chowdhary M. Unfilled Positions in the 2019 National Resident Matching Program Radiation Oncology Match and Supplemental Offer and Acceptance Program. Pract Radiat Oncol 9: 501-502, 2019.
Web Publications
- Goodman CR. Beyond the Tangents: Biomarkers and the Art of Radiotherapy, 2025.
- Goodman CR. What is radiation fibrosis? 5 things to know, 2024.
- Goodman CR. Radiation treatment for breast cancer: What to expect, 2023.
- Goodman CR, Campbell SR. Radiation Oncology Graduate Medical Education in the Time of COVID-19, 2020.
- Dover L, Goodman CR. Advocacy Day 2019: Two residents share their experiences and why they attend this annual event, 2019.
- Goodman CR, Marcrom S. An Open Letter to the American Board of Radiology Regarding the 2018 Qualifying Examinations for Radiation Oncology, 2017.
Patient Reviews
CV information above last modified September 14, 2026